Satellos price target raised to $40 from $5 at Oppenheimer

5 days ago 4

TipRanks

Wed, February 11, 2026 astatine 7:12 AM CST 1 min read

Oppenheimer raised the firm’s price target connected Satellos (MSLE) to $40 from $5 and keeps an Outperform standing connected the shares. The steadfast is updating its exemplary for U.S. listing, and adjusting for 1:12 reverse divided and its summation successful Duchenne muscular dystrophy marketplace penetration. Oppenheimer sees Satellos arsenic an arbitrage accidental successful DMD space, wherein SAT-3247 Phase II randomized information could determination Satellos up 300%-500%/-90%.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See Insiders’ Hot Stocks connected TipRanks >>

Read More connected MSLE:

Disclaimer & DisclosureReport an Issue

Satellos Bioscience to Highlight Muscle-Regeneration Platform astatine Guggenheim Biotech Summit 2026

Read Entire Article